These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24734352)

  • 1. [Present and future perspectives for the rapid molecular diagnosis of TB and MDR-TB].
    Tanasescu M; Didilescu C; Marica C
    Pneumologia; 2013; 62(4):198-205. PubMed ID: 24734352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The present and future prospects in rapid molecular diagnosis of tuberculosis and MDR-TB (First Part)].
    Tănăsescu M; Didilescu C; Marica C
    Pneumologia; 2013; 62(3):134-8. PubMed ID: 24273995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stepwise implementation of a new diagnostic algorithm for multidrug-resistant tuberculosis in Haiti.
    Gauthier M; Somoskövi A; Berland JL; Ocheretina O; Mabou MM; Boncy J; Gutierrez C; Vernet G; Pape JW
    Int J Tuberc Lung Dis; 2014 Feb; 18(2):220-6. PubMed ID: 24429317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tuberculosis].
    de la Vía E; Barón R; Molins E; Arriero JM
    Arch Bronconeumol; 2011; 47 Suppl 8():10-4. PubMed ID: 23351514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in rapid diagnosis of tuberculosis disease and anti-tuberculous drug resistance.
    Alcaide F; Coll P
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():34-40. PubMed ID: 21420565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The management of tuberculosis: epidemiology, resistance and monitoring.
    Bang D
    Dan Med Bull; 2010 Nov; 57(11):B4213. PubMed ID: 21055374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and detection of drug-resistant strains of M. tuberculosis.
    Ferraro MJ; Klietmann W; Lee JT
    AIDS Clin Care; 1995 Apr; 7(4):27-9, 36. PubMed ID: 11370656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid diagnosis of tuberculosis and multidrug resistance by the microscopic-observation drug-susceptibility assay.
    Shah NS; Moodley P; Babaria P; Moodley S; Ramtahal M; Richardson J; Heysell S; Li X; Moll A; Friedland G; Sturm AW; Gandhi NR
    Am J Respir Crit Care Med; 2011 May; 183(10):1427-33. PubMed ID: 21297071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases.
    Tabarsi P; Chitsaz E; Tabatabaei V; Baghaei P; Shamaei M; Farnia P; Marjani M; Kazempour M; Mansouri D; Masjedi MR; Velayati AA
    Am J Ther; 2011 Sep; 18(5):343-9. PubMed ID: 20535008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of the INNO-LiPA Rif. TB® line-probe assay in rapid detection of multidrug-resistant tuberculosis in Latvia.
    Skenders GK; Holtz TH; Riekstina V; Leimane V
    Int J Tuberc Lung Dis; 2011 Nov; 15(11):1546-52, i. PubMed ID: 22008771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa.
    Barnard M; Albert H; Coetzee G; O'Brien R; Bosman ME
    Am J Respir Crit Care Med; 2008 Apr; 177(7):787-92. PubMed ID: 18202343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of tuberculosis and drug resistance: what can new tools bring us?
    Drobniewski F; Nikolayevskyy V; Balabanova Y; Bang D; Papaventsis D
    Int J Tuberc Lung Dis; 2012 Jul; 16(7):860-70. PubMed ID: 22687497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Future prospects of molecular epidemiology in tuberculosis].
    Matsumoto T; Iwamoto T
    Kekkaku; 2009 Dec; 84(12):783-4. PubMed ID: 20077862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.
    van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S
    Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of GenoType® MTBDRplus assay for rapid detection of drug susceptibility testing of multi-drug resistance tuberculosis in Northern India.
    Maurya AK; Umrao J; Singh AK; Kant S; Kushwaha RA; Dhole TN
    Indian J Pathol Microbiol; 2013; 56(2):139-43. PubMed ID: 24056651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis.
    Ahmad S; Mokaddas E
    Respir Med; 2009 Dec; 103(12):1777-90. PubMed ID: 19660927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of GenoType® MTBDRplus assay to assess drug resistance and mutation patterns of multidrug-resistant tuberculosis isolates in northern India.
    Maurya AK; Singh AK; Kant S; Umrao J; Kumar M; Kushwaha RA; Nag VL; Dhole TN
    Indian J Med Microbiol; 2013; 31(3):230-6. PubMed ID: 23883707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of multidrug resistant tuberculosis.
    Daley CL; Caminero JA
    Semin Respir Crit Care Med; 2013 Feb; 34(1):44-59. PubMed ID: 23460005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.